133 4891 3310



期刊号: 1008-682X 最新影响因子: 2.644


平均审稿速度: 平均2.2月


平均录用比例: 约65%
15年 14年 13年 12年
2.644 2.596 2.530 2.140
年文章数: 130 研究方向: 男科学



Science Citation Index
Science Citation Index Expanded



PubMed Central (PMC):

杂志简介 投稿须知 中国最近发表文章

AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology (male health). Of special interest to the Journal are
Sperm Biology(Cellular and Molecular Mechanisms);
Male Reproductive System(Structure and Function);
Hormonal Regulation of Male Reproduction;
Male Infertility(Etiology, Pathogenesis, Diagnosis, Treatment and Prevention);
Semen Analysis & Sperm Functional Assays;
Sperm Selection & Quality and ART Outcomes;
Male Sexual Dysfunction;Male Puberty Development;
Male Ageing;
Prostate Diseases;
Operational Andrology;
HIV & Male Reproductive Tract Infection;
Male Contraception;
Environmental, Life Style, Genetic Factors and Male Health;
Male Reproductive Toxicology;
Male Sexual and Reproductive Health;
Disease with high prevalence in male.
As an international journal aiming at the promotion of male health research and the enhancement of academic exchange between western and Asian andrology, AJA is distributed worldwide and welcomes current Original Articles in all areas of male health, both experimental and clinical, including modern, traditional and epidemiological studies, from any part of the world. Review articles based primarily on authors’ own research on internationally important topics are accepted. Perspective articles present personal, forward-looking or speculative, reviews of a scientific topic. Opinion pieces cover a wide variety of topics that are of current interest in male health and highlight their interaction with society. Research Highlights are by invitation only and present short updates on new progress in the field of male health. Commentary articles comment on articles that have been published in AJA. Short Communications and Letters to the Editor are also welcome.

1. Preventive effects of β-cryptoxanthin against cadmium-induced oxidative stress in the rat testis.

Author: Liu XR, Wang YY, Fan HR, Wu CJ, Kumar A, Yang LG.
Journal: Asian J Androl. 2016 Apr 22. doi: 10.4103/1008-682X.173449. [Epub ahead of print]
2. A randomized clinical trial investigating treatment choice in Chinese men receiving sildenafil citrate and tadalafil for treating erectile dysfunction.

Author: Bai WJ, Li HJ, Jin JJ, Xu WP, Sebastian S, Wang XF.
Journal: Asian J Androl. 2016 Apr 22. doi: 10.4103/1008-682X.175782. [Epub ahead of print]
3. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases.

Author: Na R, Ye D, Qi J, Liu F, Lin X, Helfand BT, Brendler CB, Conran C, Gong J, Wu Y, Gao X, Chen Y, Zheng SL, Mo Z, Ding Q, Sun Y, Xu J.
Journal: Asian J Androl. 2016 Jul-Aug;18(4):525-9. doi: 10.4103/1008-682X.179857.
4. Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction.

Author: Zhu LL, Zhang Z, Jiang HS, Chen H, Chen Y, Dai YT.
Journal: Asian J Androl. 2016 May 6. doi: 10.4103/1008-682X.179532. [Epub ahead of print]
5. Novel double-layer Silastic testicular prosthesis with controlled release of testosterone in vitro, and its effects on castrated rats.

Author: Chen HX, Yang S, Ning Y, Shao HH, Ma M, Tian RH, Liu YF, Gao WQ, Li Z, Xia WL.
Journal: Asian J Androl. 2016 May 13. doi: 10.4103/1008-682X.175786. [Epub ahead of print]
6. Indirect comparison between abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer: a systematic review.

Author: Zhang W, Wu TY, Chen Q, Shi XL, Xiao GA, Zhao L, Xu CL, Zhou T, Sun YH.
Journal: Asian J Androl. 2016 May 20. doi: 10.4103/1008-682X.178483. [Epub ahead of print]
7. Risk-prediction tools in prostate cancer: the challenge of tailoring.

Author: Morlacco A, Pan J, Karnes RJ.
Journal: Asian J Androl. 2016 May 20. doi: 10.4103/1008-682X.179526. [Epub ahead of print] No abstract available.
8. The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study.

Author: Wu YS, Zhang N, Liu SH, Xu JF, Tong SJ, Cai YH, Zhang LM, Bai PD, Hu MB, Jiang HW, Na R, Ding Q, Sun YH.
Journal: Asian J Androl. 2016 May 20. doi: 10.4103/1008-682X.181192. [Epub ahead of print]
9. Comparison of surgical effect and postoperative patient experience between laparoendoscopic single-site and conventional laparoscopic varicocelectomy: a systematic review and meta-analysis.

Author: Zhang Z, Zheng SJ, Yu W, Han YF, Chen H, Chen Y, Dai YT.
Journal: Asian J Androl. 2016 May 20. doi: 10.4103/1008-682X.181194. [Epub ahead of print]
10. PlncRNA-1 induces apoptosis through the Her-2 pathway in prostate cancer cells.

Author: Yang Q, Cui ZL, Wang Q, Jin XB, Zhao Y, Wang MW, Song W, Qu HW, Kang WT.
Journal: Asian J Androl. 2016 May 27. doi: 10.4103/1008-682X.178849. [Epub ahead of print]




AJA publishes new findings in basic and...